Moderna (MRNA) Receives a Hold from Bernstein
In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
Why Moderna (MRNA) Crashed on Wednesday?
We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...
Moderna Stock Is Sliding Wednesday: Here's Why
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
S&P 500 Gains and Losses Today: Moderna Stock Plunges After Analyst Downgrade
The S&P 500 fell 0.5% on Wednesday, Jan. 29, as the Federal Reserve held interest rates steady in a move widely expected by ...
Meet the future leaders of Goldman Sachs' investment bank
Inside the careers, accomplishments, and clients of Goldman's new heads of investment banking: Kim Posnett, Matt McClure, and ...
Goldman Sachs upgrades RH on improved execution, demand trends
Goldman Sachs upgraded RH (NYSE:RH) to "Neutral" from "Sell" given improving demand trends, strategic supply chain shifts, and the company's expectation of turning free cash flow positive next year.